Cargando…
Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression
The ability of cancer cells to survive and grow in anchorage- and serum-independent conditions is well correlated with their aggressiveness. Here, using a human whole-genome shRNA library, we identify TMIGD3 isoform1 (i1) as a factor that suppresses this ability in osteosarcoma (OS) cells, mainly by...
Autores principales: | Iyer, Swathi V., Ranjan, Atul, Elias, Harold K., Parrales, Alejandro, Sasaki, Hiromi, Roy, Badal C., Umar, Shahid, Tawfik, Ossama W., Iwakuma, Tomoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133659/ https://www.ncbi.nlm.nih.gov/pubmed/27886186 http://dx.doi.org/10.1038/ncomms13561 |
Ejemplares similares
-
Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015) -
p53 as a Regulator of Lipid Metabolism in Cancer
por: Parrales, Alejandro, et al.
Publicado: (2016) -
Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
por: Iyer, Swathi V., et al.
Publicado: (2015) -
MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma
por: Ranjan, Atul, et al.
Publicado: (2018) -
Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
por: Kundu, Anup K., et al.
Publicado: (2017)